Neratinib, an irreversible pan-ErbB receptor tyrosine kinase inhibitor: results of a phase II trial in patients with advanced non-small-cell lung cancer (Q43061055)
Jump to navigation
Jump to search
scientific article published on 17 May 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Neratinib, an irreversible pan-ErbB receptor tyrosine kinase inhibitor: results of a phase II trial in patients with advanced non-small-cell lung cancer |
scientific article published on 17 May 2010 |
Statements
1 reference
Neratinib, an irreversible pan-ErbB receptor tyrosine kinase inhibitor: results of a phase II trial in patients with advanced non-small-cell lung cancer (English)
1 reference
Lecia V Sequist
1 reference
Benjamin Besse
1 reference
Thomas J Lynch
1 reference
Vincent A Miller
1 reference
Kwok K Wong
1 reference
Barbara Gitlitz
1 reference
Keith Eaton
1 reference
Charles Zacharchuk
1 reference
Amy Freyman
1 reference
Christine Powell
1 reference
Revathi Ananthakrishnan
1 reference
Susan Quinn
1 reference
17 May 2010
1 reference
1 reference
28
1 reference
18
1 reference
3076-3083
1 reference
Identifiers
1 reference
1 reference